SecBot SecBot
SECBOTREPLAY Home › Report › CVS

CVS · The District Court for the Eastern District of Pennsylvania dismissed…

CVS HEALTH Corp · COURT-RULING filed Mar 2, 2026 at 19:00 ET

At the news

BULLISHIMPACT 6/10

COURT-RULING filed Mar 2, 2026 at 19:00 ET

The District Court for the Eastern District of Pennsylvania dismissed with prejudice the antitrust tying lawsuit against CVS Health Corp and its subsidiaries. The court held that the plaintiffs' single-brand tying product market ("CVS Contract Pharmacy Market") was legally insufficient and that they failed to establish personal jurisdiction over CVS Health. This removes a material litigation overhang for CVS, as the case cannot be refiled.

  • Court granted CVS's motion to dismiss the amended complaint with prejudice on March 3, 2026.
  • Plaintiffs alleged CVS illegally tied Wellpartner TPA services to CVS Contract Pharmacy services under the 340B Drug Pricing Program.
  • Court found the single-brand tying product market ("CVS Contract Pharmacy Market") legally insufficient; Covered Entities can contract with unlimited other pharmacies.
  • Court also found it lacked personal jurisdiction over CVS Health Corp (parent company) in Pennsylvania.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access